{"id":"https://openalex.org/W1966201895","doi":"https://doi.org/10.1006/biol.1998.0148","title":"Virus Validation of PH 4-treated Human Immunoglobulin Produced by the Cohn Fractionation Process","display_name":"Virus Validation of PH 4-treated Human Immunoglobulin Produced by the Cohn Fractionation Process","alternate_titles":[],"publication_year":1998,"publication_date":"1998-12-01","ids":{"openalex":"https://openalex.org/W1966201895","doi":"https://doi.org/10.1006/biol.1998.0148","mag":"1966201895","pmid":"https://pubmed.ncbi.nlm.nih.gov/10403030"},"language":"en","primary_location":{"id":"doi:10.1006/biol.1998.0148","doi":"https://doi.org/10.1006/biol.1998.0148","is_oa":false,"landing_page_url":"https://doi.org/10.1006/biol.1998.0148","pdf_url":null,"source":{"id":"https://openalex.org/S110177920","display_name":"Biologicals","issn_l":"1045-1056","issn":["1045-1056","1095-8320"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biologicals","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1966201895"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001270746","display_name":"Octaaf J.M. Bos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3020210244","display_name":"Sanquin","ror":"https://ror.org/01fm2fv39","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I3020210244"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Octaaf J.M. Bos","raw_affiliation_strings":["Department of Product and Process Development, CLB, Sanquin Blood Supply Foundation, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Product and Process Development, CLB, Sanquin Blood Supply Foundation, The Netherlands","institution_ids":["https://openalex.org/I3020210244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5097878493","display_name":"Dominique G.J. Suny\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3020210244","display_name":"Sanquin","ror":"https://ror.org/01fm2fv39","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I3020210244"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dominique G.J. Suny\u00e9","raw_affiliation_strings":["Department of Product and Process Development, CLB, Sanquin Blood Supply Foundation, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Product and Process Development, CLB, Sanquin Blood Supply Foundation, The Netherlands","institution_ids":["https://openalex.org/I3020210244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006440614","display_name":"C E Nieuweboer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3020210244","display_name":"Sanquin","ror":"https://ror.org/01fm2fv39","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I3020210244"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carina E.F. Nieuweboer","raw_affiliation_strings":["Department of Product and Process Development, CLB, Sanquin Blood Supply Foundation, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Product and Process Development, CLB, Sanquin Blood Supply Foundation, The Netherlands","institution_ids":["https://openalex.org/I3020210244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045123563","display_name":"F. A. C. van Engelenburg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3020210244","display_name":"Sanquin","ror":"https://ror.org/01fm2fv39","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I3020210244"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Frank A.C. van Engelenburg","raw_affiliation_strings":["CLB Virus Safety Services, CLB, Sanquin Blood Supply Foundation, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CLB Virus Safety Services, CLB, Sanquin Blood Supply Foundation, The Netherlands","institution_ids":["https://openalex.org/I3020210244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014967648","display_name":"Hanneke Schuitemaker","orcid":"https://orcid.org/0000-0001-8563-2266","observed_orcids":["https://orcid.org/0000-0001-8563-2266"]},"institutions":[{"id":"https://openalex.org/I3020210244","display_name":"Sanquin","ror":"https://ror.org/01fm2fv39","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I3020210244"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hanneke Schuitemaker","raw_affiliation_strings":["CLB Virus Safety Services, CLB, Sanquin Blood Supply Foundation, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CLB Virus Safety Services, CLB, Sanquin Blood Supply Foundation, The Netherlands","institution_ids":["https://openalex.org/I3020210244"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109572894","display_name":"Jan Over","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3020210244","display_name":"Sanquin","ror":"https://ror.org/01fm2fv39","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I3020210244"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jan Over","raw_affiliation_strings":["Department of Product and Process Development, CLB, Sanquin Blood Supply Foundation, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Product and Process Development, CLB, Sanquin Blood Supply Foundation, The Netherlands","institution_ids":["https://openalex.org/I3020210244"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5109572894"],"corresponding_institution_ids":["https://openalex.org/I3020210244"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":0.7131,"has_fulltext":false,"cited_by_count":48,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.63836166,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"26","issue":"4","first_page":"267","last_page":"276"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.5390999913215637,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.5390999913215637,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11455","display_name":"Microbial Inactivation Methods","score":0.14509999752044678,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.12610000371932983,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/human-immunoglobulin","display_name":"human immunoglobulin","score":0.8140000104904175},{"id":"https://openalex.org/keywords/intravenous-immunoglobulin","display_name":"intravenous immunoglobulin","score":0.843999981880188},{"id":"https://openalex.org/keywords/intramuscular-immunoglobulin","display_name":"intramuscular immunoglobulin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cohn-fractionation","display_name":"Cohn fractionation","score":0.7829999923706055},{"id":"https://openalex.org/keywords/virus-inactivation","display_name":"virus inactivation","score":0.8209999799728394},{"id":"https://openalex.org/keywords/virus-reduction","display_name":"virus reduction","score":0.5860000252723694},{"id":"https://openalex.org/keywords/viral-safety","display_name":"viral safety","score":0.7509999871253967},{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.8429999947547913},{"id":"https://openalex.org/keywords/bovine-viral-diarrhea-virus","display_name":"bovine viral diarrhea virus","score":0.9829999804496765},{"id":"https://openalex.org/keywords/pseudorabies-virus","display_name":"pseudorabies virus","score":0.9980000257492065},{"id":"https://openalex.org/keywords/simian-virus-40","display_name":"simian virus 40","score":0.9950000047683716},{"id":"https://openalex.org/keywords/encephalomyocarditis-virus","display_name":"encephalomyocarditis virus","score":0.9990000128746033},{"id":"https://openalex.org/keywords/lipid-enveloped-viruses","display_name":"lipid-enveloped viruses","score":0.8730000257492065}],"concepts":[{"id":"https://openalex.org/C2781092067","wikidata":"https://www.wikidata.org/wiki/Q316180","display_name":"Pseudorabies","level":3,"score":0.8451845645904541},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.7972592711448669},{"id":"https://openalex.org/C97428945","wikidata":"https://www.wikidata.org/wiki/Q15305109","display_name":"Fractionation","level":2,"score":0.7204954028129578},{"id":"https://openalex.org/C106358424","wikidata":"https://www.wikidata.org/wiki/Q1662346","display_name":"Infectivity","level":3,"score":0.5501037240028381},{"id":"https://openalex.org/C97380033","wikidata":"https://www.wikidata.org/wiki/Q994215","display_name":"Viral envelope","level":3,"score":0.5330281257629395},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4999680519104004},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.47975075244903564},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4523724317550659},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.3242185115814209},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.29994919896125793},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.10070550441741943}],"mesh":[{"descriptor_ui":"D000431","descriptor_name":"Ethanol","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000914","descriptor_name":"Antibodies, Viral","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000914","descriptor_name":"Antibodies, Viral","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":true},{"descriptor_ui":"D001908","descriptor_name":"Diarrhea Viruses, Bovine Viral","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D002417","descriptor_name":"Cattle","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002522","descriptor_name":"Chlorocebus aethiops","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003080","descriptor_name":"Cold Temperature","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004686","descriptor_name":"Encephalomyocarditis virus","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D005591","descriptor_name":"Chemical Fractionation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007136","descriptor_name":"Immunoglobulins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007136","descriptor_name":"Immunoglobulins","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":true},{"descriptor_ui":"D007273","descriptor_name":"Injections, Intramuscular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011558","descriptor_name":"Herpesvirus 1, Suid","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D013539","descriptor_name":"Simian virus 40","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014709","descriptor_name":"Vero Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015483","descriptor_name":"HIV Antibodies","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015483","descriptor_name":"HIV Antibodies","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015498","descriptor_name":"HIV-2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1006/biol.1998.0148","doi":"https://doi.org/10.1006/biol.1998.0148","is_oa":false,"landing_page_url":"https://doi.org/10.1006/biol.1998.0148","pdf_url":null,"source":{"id":"https://openalex.org/S110177920","display_name":"Biologicals","issn_l":"1045-1056","issn":["1045-1056","1095-8320"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biologicals","raw_type":"journal-article"},{"id":"pmid:10403030","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10403030","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biologicals : journal of the International Association of Biological Standardization","raw_type":"Journal Article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/6912f060-ee60-4caf-a062-a0a65aa5e30b","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/6912f060-ee60-4caf-a062-a0a65aa5e30b","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bos, O J, Suny\u00e9, D G, Nieuweboer, C E, van Engelenburg, F A, Schuitemaker, H & Over, J 1998, 'Virus validation of pH 4-treated human immunoglobulin products produced by the Cohn fractionation process', Biologicals, vol. 26, no. 4, pp. 267-276. https://doi.org/10.1006/biol.1998.0148","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/14779ade-9605-4f07-bddf-bf29505f990d","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/virus-validation-of-ph-4treated-human-immunoglobulin-products-produced-by-the-cohn-fractionation-process(14779ade-9605-4f07-bddf-bf29505f990d).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Biologicals, 26(4), 267 - 276. Academic Press Inc.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8199999928474426}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2353760621","https://openalex.org/W2210557692","https://openalex.org/W1930539534","https://openalex.org/W2145591068","https://openalex.org/W2395961878","https://openalex.org/W2163098040","https://openalex.org/W1968289980","https://openalex.org/W2077456805","https://openalex.org/W2019556666","https://openalex.org/W2028099188"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1966201895","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
